{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:01:59Z","timestamp":1794614519193,"version":"4.9.1"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:p>\n                    We report a patient with stage IIA (cT2bN0M0) lung adenocarcinoma who developed new diffuse pleural, pulmonary, and nodal FDG uptake on\n                    <jats:sup>18<\/jats:sup>\n                    FDG-PET\/CT after three cycles of neoadjuvant nivolumab plus cisplatin\u2013pemetrexed, with slight regression of the primary tumour. These findings raised the diagnostic dilemma between disease progression and immune checkpoint inhibitor (ICI)-related sarcoid-like reaction (SLR). Rapid clinical and metabolic improvement after corticosteroid therapy supported SLR, which was subsequently confirmed histologically by noncaseating granulomas without viable tumour at surgery. This case highlights pleural involvement in SLR as a rare and diagnostically challenging immune-related adverse event.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006710","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T17:01:44Z","timestamp":1792774904000},"page":"e1088-e1090","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Sarcoid-like Reaction With Pleural Involvement After Neoadjuvant Chemo-immunotherapy For Lung Cancer"],"prefix":"10.1097","volume":"51","author":[{"given":"Arne","family":"Coussement","sequence":"first","affiliation":[{"name":"Department of Pneumology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Mol","sequence":"additional","affiliation":[{"name":"Department of Pneumology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennert","family":"Boeckxstaens","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Vanstapel","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Wauters","sequence":"additional","affiliation":[{"name":"Department of Pneumology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1038\/s41467-021-25188-0","article-title":"Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer","volume":"12","author":"Cascone","year":"2021","journal-title":"Nat Commun"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2174\/1874471013666191230144821","article-title":"18F-FDG PET\/CT in restaging and evaluation of response to therapy in lung cancer: state of the art","volume":"13","author":"Castello","year":"2020","journal-title":"Curr Radiopharm"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jtho.2018.04.031","article-title":"Sarcoidosis-like reactions induced by checkpoint inhibitors","volume":"13","author":"Gkiozos","year":"2018","journal-title":"J Thorac Oncol"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/RLU.0000000000006058","article-title":"Drug-induced sarcoid-like reaction presenting as fascitis","volume":"50","author":"Jayade","year":"2025","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:00:20Z","timestamp":1793826020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006710"}},"subtitle":["A Rare Mimic of Disease Progression"],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006710","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"2026-05-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}